CATHERINE MYERS: Open Payments
NPI 1063060515 · EASTON, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$633 in 13 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $208 · 2025 $633
Food & beverage: $633
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $269 |
| E.R. Squibb & Sons, L.L.C. | 2 | $130 |
| Supernus Pharmaceuticals, Inc. | 1 | $113 |
| Janssen Pharmaceuticals, Inc | 2 | $51 |
| Otsuka America Pharmaceutical, Inc. | 3 | $44 |
| ABBVIE INC. | 1 | $25 |
Products named: CAPLYTA, COBENFY, Qelbree, INVEGA SUSTENNA, REXULTI, VRAYLAR.
Industry payments across PA — which companies pay providers there.
